|

Nicorandil Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • Korea University Anam Hospital1

Indications

  • No-Reflow Phenomenon1
  • Percutaneous Coronary Intervention1
  • Heart Disease1
  • Coronary Artery Disease1

Other1 trial

A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.